What's breaking now, across thousands of outlets.
Key PointsJohnson & Johnson is still dealing with the fallout from the loss of patent protection for one of its former top-selling drugs, Stelara.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
(RTTNews) - The Treasury Department on Thursday announced the details of this month's auctions of two-year, five-year and seven-year notes.
DBS Group Research economist Radhika Rao notes Bank Indonesia (BI) kept its policy rate at 5.75% with Acting Governor Destry maintaining a neutral bias while flagging global risks.
Twenty soldiers have already accepted a U.S. Army offer for pass to play GTA VI—but they must commit to a two-year reenlistment.
While many sellers nationwide are accepting discounts, nearly every top-ranked zip code continues to spark bidding wars.
Eli Lilly’s triple agonist retatrutide appears to be the most effective obesity drug to have reached late-stage trials, with weight loss of up to 25% in Phase 3. This has led growing ...
West Texas Intermediate (WTI) US Oil rises 1.89% on Thursday and trades around $85.85 at the time of writing, after reaching a fresh three-week high at $87.38 earlier in the day.
